Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Phospho-c-Met (Tyr1003), Polyclonal, Invitrogen™

Rabbit Polyclonal Antibody

Manufacturer:  Invitrogen PA128461

Catalog No. PIPA128461

This item has been discontinued by the manufacturer and is no longer available. Please call customer service for assistance: 1-800-766-7000.


Description

Description

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

PA1-28461 detects c-Met from human samples.PA1-28461 has been successfully used in Western blot applications.The PA1-28461 immunogen is: Synthetic phosphopeptide derived from the region of c-Met that contains tyrosine 1003.
Specifications

Specifications

Phospho-c-Met pTyr1003
Polyclonal
PBS with 1mg/mL BSA and 0.05% sodium azide; pH 7.4
P08581, P16056, P97523
AUTS9, HGFR, RCCP2, c-Met
Rabbit
IgG
50μL
Store at -20°C
Primary
4233
Western Blot
Unconjugated
MET
Purified
MET
Synthetic phosphopeptide derived from the region of c-Met that contains tyrosine 1003.
Antigen affinity chromatography
RUO
Antibody
Polyclonal
Human, Murine, Rat
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit